Dyne Therapeutics (DYN) Earnings Date, Estimates & Call Transcripts

$25.44
+0.57 (+2.29%)
(As of 05:12 PM ET)

Earnings Summary

Upcoming
Earnings Date
May. 9Estimated
Actual EPS
(Mar. 5)
-$1.09 Missed By -$0.17
Consensus EPS
(Mar. 5)
-$0.92
Skip Charts & View Estimated and Actual Earnings Data

DYN Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

DYN Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Dyne Therapeutics Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20241($0.83)($0.83)($0.83)
Q2 20241($0.83)($0.83)($0.83)
Q3 20241($0.84)($0.84)($0.84)
Q4 20241($0.84)($0.84)($0.84)
FY 20244($3.34)($3.34)($3.34)

DYN Earnings Date and Information

Dyne Therapeutics last posted its quarterly earnings results on March 5th, 2024. The reported ($1.09) EPS for the quarter, missing the consensus estimate of ($0.92) by $0.17. Dyne Therapeutics has generated ($3.94) earnings per share over the last year (($3.94) diluted earnings per share). Earnings for Dyne Therapeutics are expected to grow in the coming year, from ($3.25) to ($3.14) per share. Dyne Therapeutics has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, May 9th, 2024 based off prior year's report dates.

Dyne Therapeutics Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
5/9/2024
Estimated)
------- 
3/5/2024Q4 2023($0.92)($1.09)($0.17)($1.09)--
10/30/2023Q3 2023($0.83)($0.99)($0.16)($0.99)--
8/3/2023Q2 2023($0.81)($1.08)($0.27)($1.08)--
5/11/2023Q1 2023($0.77)($0.78)($0.01)($0.78)--
5/11/2023Q1 2023($0.77)($0.78)($0.01)($0.78)--
5/11/2023Q1 2023($0.77)($0.78)($0.01)($0.78)--
5/11/2023Q1 2023($0.77)($0.78)($0.01)($0.78)--
5/11/2023Q1 2023($0.77)($0.78)($0.01)($0.78)--
5/11/2023Q1 2023($0.77)($0.78)($0.01)($0.78)--
3/2/2023Q4 2022($0.84)($0.74)+$0.10($0.74)--
3/2/2023Q4 2022($0.84)($0.74)+$0.10($0.74)--
3/2/2023Q4 2022($0.84)($0.74)+$0.10($0.74)--
3/2/2023Q4 2022($0.84)($0.74)+$0.10($0.74)--
3/2/2023Q4 2022($0.84)($0.74)+$0.10($0.74)--
3/2/2023Q4 2022($0.84)($0.74)+$0.10($0.74)--
11/3/2022Q3 2022($0.95)($0.80)+$0.15($0.80)--
11/3/2022Q3 2022($0.95)($0.80)+$0.15($0.80)--
11/3/2022Q3 2022($0.95)($0.80)+$0.15($0.80)--
11/3/2022Q3 2022($0.95)($0.80)+$0.15($0.80)--
11/3/2022Q3 2022($0.95)($0.80)+$0.15($0.80)--
11/3/2022Q3 2022($0.95)($0.80)+$0.15($0.80)--
8/4/2022Q2 2022($0.79)($1.01)($0.22)($1.01)--
8/4/2022Q2 2022($0.79)($1.01)($0.22)($1.01)--
8/4/2022Q2 2022($0.79)($1.01)($0.22)($1.01)--
8/4/2022Q2 2022($0.79)($1.01)($0.22)($1.01)--
8/4/2022Q2 2022($0.79)($1.01)($0.22)($1.01)--
8/4/2022Q2 2022($0.79)($1.01)($0.22)($1.01)--
5/2/2022Q1 2022($0.88)($0.69)+$0.19($0.69)--
5/2/2022Q1 2022($0.88)($0.69)+$0.19($0.69)--
5/2/2022Q1 2022($0.88)($0.69)+$0.19($0.69)--
5/2/2022Q1 2022($0.88)($0.69)+$0.19($0.69)--
5/2/2022Q1 2022($0.88)($0.69)+$0.19($0.69)--    
5/2/2022Q1 2022($0.88)($0.69)+$0.19($0.69)--
5/2/2022Q1 2022($0.88)($0.69)+$0.19($0.69)--
3/10/2022Q4 2021($0.99)($1.00)($0.01)($1.00)--
3/10/2022Q4 2021($0.99)($1.00)($0.01)($1.00)--
3/10/2022Q4 2021($0.99)($1.00)($0.01)($1.00)--
3/10/2022Q4 2021($0.99)($1.00)($0.01)($1.00)--
3/10/2022Q4 2021($0.99)($1.00)($0.01)($1.00)--
3/10/2022Q4 2021($0.99)($1.00)($0.01)($1.00)--
Thousands of investors use this no cost solution | Do you? (Ad)

In today’s volatile markets we are all looking for the edge. But imagine tapping into a world where every investment move has the potential to be ahead of the curve. Most investors have heard of the publication Insider Financial. For nearly a decade, they've unlocked doors to opportunities tucked away from the public eye, guiding over a million investors with well researched information before it hits the mainstream media.

Simply tap here now to subscribe and start getting "Insider Financial Advantage"
3/10/2022Q4 2021($0.99)($1.00)($0.01)($1.00)--
11/4/2021Q3 2021($0.65)($0.83)($0.18)($0.83)--
11/4/2021Q3 2021($0.65)($0.83)($0.18)($0.83)--
11/4/2021Q3 2021($0.65)($0.83)($0.18)($0.83)--
11/4/2021Q3 2021($0.65)($0.83)($0.18)($0.83)--
11/4/2021Q3 2021($0.64)($0.83)($0.19)($0.83)--
11/4/2021Q3 2021($0.65)($0.83)($0.18)($0.83)--
11/4/2021Q3 2021($0.65)($0.83)($0.18)($0.83)--
8/5/2021Q2 2021($0.55)($0.58)($0.03)($0.58)--
8/5/2021Q2 2021($0.55)($0.58)($0.03)($0.58)--
8/5/2021Q2 2021($0.55)($0.58)($0.03)($0.58)--
8/5/2021Q2 2021($0.55)($0.58)($0.03)($0.58)--
8/5/2021Q2 2021($0.55)($0.58)($0.03)($0.58)--
8/5/2021Q2 2021($0.55)($0.58)($0.03)($0.58)--
8/5/2021Q2 2021($0.55)($0.58)($0.03)($0.58)--
5/6/2021Q1 2021($0.60)($0.50)+$0.10($0.50)--
5/6/2021Q1 2021($0.60)($0.50)+$0.10($0.50)--
5/6/2021Q1 2021($0.60)($0.50)+$0.10($0.50)--
5/6/2021Q1 2021($0.60)($0.50)+$0.10($0.50)--
5/6/2021Q1 2021($0.60)($0.50)+$0.10($0.50)--
5/6/2021Q1 2021($0.60)($0.50)+$0.10($0.50)--
5/6/2021Q1 2021($0.60)($0.50)+$0.10($0.50)--  

Dyne Therapeutics Earnings - Frequently Asked Questions

When is Dyne Therapeutics's earnings date?

Dyne Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, May 9th, 2024 based off last year's report dates. Learn more on DYN's earnings history.

Did Dyne Therapeutics beat their earnings estimates last quarter?

In the previous quarter, Dyne Therapeutics (NASDAQ:DYN) missed the analysts' consensus estimate of ($0.92) by $0.17 with a reported earnings per share (EPS) of ($1.09). Learn more on analysts' earnings estimate vs. DYN's actual earnings.

How much profit does Dyne Therapeutics generate each year?

Dyne Therapeutics (NASDAQ:DYN) has a recorded net income of -$235.94 million. DYN has generated -$3.94 earnings per share over the last four quarters.

What is Dyne Therapeutics's EPS forecast for next year?

Dyne Therapeutics's earnings are expected to grow from ($3.25) per share to ($3.14) per share in the next year.


More Earnings Resources from MarketBeat

This page (NASDAQ:DYN) was last updated on 4/23/2024 by MarketBeat.com Staff

From Our Partners